🚀 VC round data is live in beta, check it out!
- Public Comps
- Challenger
Challenger Valuation Multiples
Discover revenue and EBITDA valuation multiples for Challenger and similar public comparables like Covivio Hotels, Grupo SURA, Oscar Health, Lemonade and more.
Challenger Overview
About Challenger
Challenger’s core business is selling annuity products in the Australian retirement market and, since November 2016, selling Australian dollar-denominated annuities into Japan's large retirement market. The firm’s annuity products provide investors guaranteed regular payments over an agreed term for an upfront lump sum investment and is designed primarily to protect investors from the longevity risk of outliving their savings. Challenger also operates a funds management business, Fidante Partners, which has minority stakes in several boutique global investment managers, and Challenger Investment Management, which primarily manages investments supporting its annuities business.
Founded
2003
HQ

Employees
576
Website
Financials (LTM)
Market Cap
$4B
Challenger Financials
Challenger reported last 12-month revenue of $674M and EBITDA of $465M.
In the same LTM period, Challenger generated $457M in gross profit, $465M in EBITDA, and $316M in net income.
Revenue (LTM)
Challenger P&L
In the most recent fiscal year, Challenger reported revenue of $632M and EBITDA of $767M.
Challenger expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $674M | XXX | $632M | XXX | XXX | XXX |
| Gross Profit | $457M | XXX | $517M | XXX | XXX | XXX |
| Gross Margin | 68% | XXX | 82% | XXX | XXX | XXX |
| EBITDA | $465M | XXX | $767M | XXX | XXX | XXX |
| EBITDA Margin | 69% | XXX | 121% | XXX | XXX | XXX |
| EBIT Margin | 69% | XXX | 68% | XXX | XXX | XXX |
| Net Profit | $316M | XXX | $294M | XXX | XXX | XXX |
| Net Margin | 47% | XXX | 47% | XXX | XXX | XXX |
| Net Debt | — | — | $5B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Challenger Stock Performance
Challenger has current market cap of $4B.
Market Cap Evolution
Challenger's stock price is $5.96.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $4B | 0.0% | XXX | XXX | XXX | $0.43 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialChallenger Valuation Multiples
Challenger trades at (2.7x) EV/Revenue multiple, and (3.9x) EV/EBITDA.
EV / Revenue (LTM)
Challenger Financial Valuation Multiples
As of March 29, 2026, Challenger has market cap of $4B.
Equity research analysts estimate Challenger's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Challenger has a P/E ratio of 13.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV (current) | ($2B) | XXX | ($2B) | XXX | XXX | XXX |
| EV/Revenue | (2.7x) | XXX | (2.9x) | XXX | XXX | XXX |
| EV/EBITDA | (3.9x) | XXX | (2.4x) | XXX | XXX | XXX |
| EV/EBIT | (3.9x) | XXX | (4.2x) | XXX | XXX | XXX |
| EV/Gross Profit | (4.0x) | XXX | (3.5x) | XXX | XXX | XXX |
| P/E | 13.0x | XXX | 14.0x | XXX | XXX | XXX |
| EV/FCF | (8.0x) | XXX | (6.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Challenger Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Challenger Margins & Growth Rates
Challenger's revenue in the last 12 month grew by 7%.
Challenger's revenue per employee in the last FY averaged $1.1M, while opex per employee averaged $2.4M for the same period.
Challenger's rule of 40 is 87% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Challenger's rule of X is 114% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Challenger Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | 69% | XXX | 121% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | (38%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 87% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 114% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $2.4M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 21% | XXX | XXX | XXX |
| Opex to Revenue | 32% | XXX | 216% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Challenger Public Comps
See public comps and valuation multiples for other Asset Management and Insurance Carriers comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Covivio Hotels | XXX | XXX | XXX | XXX | XXX | XXX |
| Grupo SURA | XXX | XXX | XXX | XXX | XXX | XXX |
| Oscar Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Lemonade | XXX | XXX | XXX | XXX | XXX | XXX |
| Cofinimmo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Challenger M&A Activity
Challenger acquired XXX companies to date.
Last acquisition by Challenger was on XXXXXXXX, XXXXX. Challenger acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Challenger
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialChallenger Investment Activity
Challenger invested in XXX companies to date.
Challenger made its latest investment on XXXXXXXX, XXXXX. Challenger invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Challenger
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Challenger
| When was Challenger founded? | Challenger was founded in 2003. |
| Where is Challenger headquartered? | Challenger is headquartered in Australia. |
| How many employees does Challenger have? | As of today, Challenger has over 576 employees. |
| Who is the CEO of Challenger? | Challenger's CEO is Nicolas Hamilton. |
| Is Challenger publicly listed? | Yes, Challenger is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Challenger? | Challenger trades under CGF ticker. |
| When did Challenger go public? | Challenger went public in 2003. |
| Who are competitors of Challenger? | Challenger main competitors are Covivio Hotels, Grupo SURA, Oscar Health, Lemonade. |
| What is the current market cap of Challenger? | Challenger's current market cap is $4B. |
| What is the current revenue of Challenger? | Challenger's last 12 months revenue is $674M. |
| What is the current revenue growth of Challenger? | Challenger revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Challenger? | Current revenue multiple of Challenger is (2.7x). |
| Is Challenger profitable? | Yes, Challenger is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Challenger? | Challenger's last 12 months EBITDA is $465M. |
| What is Challenger's EBITDA margin? | Challenger's last 12 months EBITDA margin is 69%. |
| What is the current EV/EBITDA multiple of Challenger? | Current EBITDA multiple of Challenger is (3.9x). |
| What is the current FCF of Challenger? | Challenger's last 12 months FCF is $226M. |
| What is Challenger's FCF margin? | Challenger's last 12 months FCF margin is 34%. |
| What is the current EV/FCF multiple of Challenger? | Current FCF multiple of Challenger is (8.0x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.